CSIMarket
 


Invo Bioscience Inc   (INVO)
Other Ticker:  
 

Invo Bioscience Inc 's Tangible Leverage Ratio

INVO's quarterly Tangible Leverage Ratio and Total Liabilities, Tangible Equity growth




INVO Tangible Leverage Ratio (Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Tangible Equity Change -50.54 % -25.66 % - - -
Y / Y Total Liabilities Change -41.91 % -48.11 % - - -
Tangible Leverage Ratio MRQ 2.74 0.88 0.5 0.41 2.33
Overall Ranking # 2927 # 0 # 0 # 0 # 3039
Seq. Tangible Equity Change -64.19 % -40.93 % -23.98 % 207.51 % -46.16 %
Seq. Total Liabilities Change 11.27 % 5.02 % -7.77 % -46.1 % -0.59 %



Tangible Leverage Ratio third quarter 2022 Comment
Due to net new borrowings of 11.27%, Tangible Leverage Ratio detoriated to 2.74, above company's average Tangible Leverage Ratio.

Within Medical Equipment & Supplies industry in the third quarter 2022, 155 other companies have achieved lower Tangible Leverage Ratio than Invo Bioscience Inc . While Tangible Leverage Ratio total ranking has deteriorated compare to the previous quarter from 0 to 2927.

Explain Tangible Leverage Ratio?
What is INVO Market Share?
Tangible Leverage Ratio third quarter 2022 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 156
Healthcare Sector # 842
Overall Market # 2927


Tangible Leverage Ratio Statistics
High Average Low
2.46 1.29 0.4
(Sep 30 2022)   (Dec 31 2021)




Financial Statements
Invo Bioscience Inc 's Tangible Equity $ 1 Millions Visit INVO's Balance sheet
Invo Bioscience Inc 's Total Liabilities $ 3 Millions Visit INVO's Balance sheet
Source of INVO's Sales Visit INVO's Sales by Geography


Cumulative Invo Bioscience Inc 's Tangible Leverage Ratio

INVO's Tangible Leverage Ratio for the trailling 12 Months

INVO Tangible Leverage Ratio

(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Tangible Equity TTM Growth -50.54 % -25.66 % - - -
Y / Y Total Liabilities TTM Growth -41.91 % -48.11 % - - -
Tangible Leverage Ratio TTM 0.68 0.77 0.86 1 1.64
Total Ranking TTM # 1309 # 1657 # 1660 # 1691 # 0
Seq. Tangible Equity TTM Growth -64.19 % -40.93 % -23.98 % 207.51 % -46.16 %
Seq. Total Liabilities TTM Growth 11.27 % 5.02 % -7.77 % -46.1 % -0.59 %


TTM Tangible Leverage Ratio Comment
On the trailing twelve months basis Despite of the net new borrowings of 11.27% Invo Bioscience Inc managed to decrease Tangible Leverage Ratio in III. Quarter to 0.68, below Invo Bioscience Inc 's average Tangible Leverage Ratio.
Tangible Leverage Ratio is the average cumulative value over the last four quarters.

Among companies in the Medical Equipment & Supplies industry 96 other companies have achieved lower Tangible Leverage Ratio than Invo Bioscience Inc . While total ranking remained unchanged compare to previous quarter at no. 1309.

Explain Tangible Leverage Ratio?
What is INVO Market Share?

TTM Tangible Leverage Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 97
Healthcare Sector # 573
Within the Market # 1309


TTM Tangible Leverage Ratio Statistics
High Average Low
0.89 0.81 0.72
(Mar 31 2022)  




Companies with similar Tangible Leverage Ratio in the quarter ending Sep 30 2022, within Medical Equipment & Supplies Industry Tangible Leverage RatioSep 30 2022 MRQ Total LiabilitiesSep 30 2022 MRQ Tangible Equity
Insulet Corporation  5.38 $ 1,734.700  Millions$ 322.700  Millions
Henry Schein Inc   5.28 $ 3,909.000  Millions$ 740.000  Millions
Yunhong Cti Ltd   4.80 $ 13.499  Millions$ 2.815  Millions
Avinger Inc  4.65 $ 23.005  Millions$ 4.946  Millions
Tactile Systems Technology Inc   4.19 $ 134.129  Millions$ 32.026  Millions
Harpoon Therapeutics Inc   3.94 $ 66.584  Millions$ 16.912  Millions
Tessco Technologies Incorporated  3.77 $ 153.103  Millions$ 40.624  Millions
Ufp Technologies Inc  3.65 $ 162.160  Millions$ 44.461  Millions
Escalon Medical Corp   3.52 $ 3.770  Millions$ 1.072  Millions
Better Therapeutics Inc   2.89 $ 20.969  Millions$ 7.252  Millions
Invo Bioscience Inc   2.74 $ 3.162  Millions$ 1.155  Millions
Glaukos Corp  2.73 $ 459.914  Millions$ 168.323  Millions
Tela Bio Inc   2.72 $ 56.262  Millions$ 20.707  Millions
Patterson Companies Inc   2.68 $ 1,791.579  Millions$ 669.263  Millions
Biolase Inc   2.65 $ 29.007  Millions$ 10.932  Millions
The Cooper Companies Inc   2.51 $ 4,224.200  Millions$ 1,679.900  Millions
Pavmed Inc   2.46 $ 60.492  Millions$ 24.606  Millions
Te Connectivity Ltd   2.34 $ 9,980.000  Millions$ 4,256.000  Millions
Angiodynamics Inc   2.21 $ 143.611  Millions$ 65.027  Millions
Apollo Endosurgery inc   2.19 $ 73.716  Millions$ 33.661  Millions
Biosig Technologies Inc   2.03 $ 3.088  Millions$ 1.522  Millions
Cerus Corporation  1.98 $ 142.283  Millions$ 71.804  Millions
Silk Road Medical Inc   1.84 $ 105.346  Millions$ 57.198  Millions
Star Equity Holdings Inc   1.80 $ 36.766  Millions$ 20.381  Millions
Neuropace Inc   1.76 $ 76.373  Millions$ 43.409  Millions
Dexcom Inc   1.67 $ 2,969.000  Millions$ 1,775.400  Millions
Resmed Inc   1.51 $ 1,744.673  Millions$ 1,155.893  Millions
Novocure Limited  1.49 $ 664.764  Millions$ 445.401  Millions
Infusystem Holdings Inc  1.45 $ 51.174  Millions$ 35.292  Millions
Voxx International Corporation  1.44 $ 222.708  Millions$ 154.320  Millions

Date modified: 2022-11-26T14:24:08+00:00

Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

COIL's Profile

Stock Price

COIL's Financials

Business Description

Fundamentals

Charts & Quotes

COIL's News

Suppliers

COIL's Competitors

Customers & Markets

Economic Indicators

COIL's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071